What’s on the Horizon for Glaucoma Treatment and Detection?

By Mary Kane
Friday, January 13, 2023 8:30 AM According to the Centers for Disease Control and Prevention, about three million Americans have glaucoma and the disease is the second leading cause of blindness worldwide. January is officially National Glaucoma Awareness month and during this time, it’s important to spread the word about this group of diseases that affects many Americans every year. VMAIL Weekend recently sat down with Ashish Singh, MD, who specializes in cataract and refractive surgery at Kleiman Evangelista Eye Centers. Here’s what he had to say about the early signs of glaucoma, encouraging high-risk patients to get screened on a regular basis and new glaucoma treatments.

Neurotech Pharmaceuticals, Inc. Expands Executive Team With the Appointment of Scott Hunter as Chief Commercial Officer

By Staff
Friday, January 13, 2023 12:21 AM CUMBERLAND, R.I.—Neurotech Pharmaceuticals, Inc., a clinical stage biotech company, announced the expansion of its executive team with the appointment of Scott Hunter as chief commercial officer bringing two decades of eyecare experience across both rare disease and specialty markets. "Scott’s appointment as the company’s first chief commercial officer marks an important milestone for Neurotech.

STAAR Surgical’s Caren Mason to Retire, Thomas Frinzi Is Named New President

By Staff
Wednesday, December 21, 2022 12:27 AM LAKE FOREST, Calif.—STAAR Surgical Company, a leading developer, manufacturer and marketer of implantable lenses for the eye, announced that president and CEO Caren Mason will be retiring on Dec. 31, 2022, after leading the company through a significant period of revitalization and growth for more than seven years.

Prism Vision Group Expands Further Into the DMV Market, Partnering With its 6th Ambulatory Surgery Center (ASC)

By Staff
Monday, December 19, 2022 12:18 AM NEW PROVIDENCE, N.J.—Prism Vision Group (PVG), the large vertically integrated eye care services organization operating exclusively on the East Coast, has welcomed Lakeview Surgery Center, Bowie, Md., to its growing platform of both ophthalmology practices and surgery centers. Lakeview Surgery Center, a 9,900-square-foot facility that showcases two operating suites, exclusively provides ophthalmic surgery five days per week. Its clinical leadership includes Medical Director, Dr. Alyson Hall, and Drs. Jonathan Solomon, John Choi, and Omar Ahmad.

Parexel Teams With MyEyeDr. to Increase Patient Access and Participation in Ophthalmology Clinical Trials

By Staff
Thursday, December 15, 2022 8:30 AM BOSTON and DURHAM, N.C.—Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today has announced a formal agreement with MyEyeDr., a leading vision healthcare organization with over 850 offices across the U.S., to refer its patients into existing and future ophthalmology clinical trials. Parexel and MyEyeDr. are currently collaborating on recruitment for a diabetic retinopathy clinical trial with future plans to expand into additional therapeutic areas such as endocrinology.

UC Davis Health Opens New State-of-the-Art Eyecare Facility in Sacramento

By Staff
Tuesday, December 13, 2022 12:21 AM SACRAMENTO, Calif.—UC Davis Health welcomed patients earlier this month to its new, state-of-the-art Ernest E. Tschannen Eye Institute Building, a new innovative facility dedicated to advancing world-class eyecare and offering hope for sight restoration.

Researchers Find Symptoms of Stress-Induced Retinal Aging and Natural Aging Are Similar

By Staff
Monday, December 5, 2022 12:15 AM IRVINE, Calif.—New research from the University of California, Irvine, suggests aging is an important component of retinal ganglion cell death in glaucoma, and that novel pathways can be targeted when designing new treatments for glaucoma patients.

Sightpath Medical Acquires Accusite Surgical

By Staff
Tuesday, November 29, 2022 12:18 AM BLOOMINGTON, Minn.—Sightpath Medical, a leading provider of mobile ophthalmic services for cataract and refractive surgery, announced that it has acquired Accusite Surgical, a cataract surgery equipment outsourcing company.

SVision Imaging Rebrands as Intalight, Names Joe Garibaldi as COO

By Staff
Friday, November 18, 2022 12:27 AM MILPITAS, Calif.—SVision Imaging, a company that develops advanced ophthalmic technologies such as optical coherence tomography (OCT), is rebranding under the new name Intalight.

EyeSouth Partners Affiliates With University Retina and Macula Associates, Representing the Network’s 34th Affiliation and Third in Illinois

By Staff
Wednesday, November 16, 2022 12:27 AM ATLANTA—EyeSouth Partners announced it has completed an affiliation with University Retina and Macula Associates. The affiliation represents EyeSouth’s third in the state of Illinois and 34th affiliation overall.

Many Parents Don’t Seek Medical Help When Their Child Get Pink Eye, New Study Reveals

By Staff
Tuesday, November 15, 2022 1:55 PM As most eyecare professionals know, pink eye, an inflammation of the transparent membrane in the eye, is one of the most common eye conditions that children can develop. It is most common in children under the age of seven.

30 percent of parents say they don’t go to the doctor or urgent care if they think their child has pink eye, according to a new study by MyVision.org.

Sight360 Acquires Florida Ophthalmology Practice

By Staff
Thursday, November 10, 2022 12:24 AM TAMPA, Fla.—Sight360, a comprehensive vision care services organization, announced it has acquired the ophthalmology practice of Larry Goldberg, MD, in St. Petersburg, Fla. The terms of the transaction were not disclosed.

Vision Integrated Partners Expands in Greater Kansas City Market

By Staff
Wednesday, November 9, 2022 12:24 AM NEW YORK—Vision Integrated Partners, a managed services organization backed by Firmament that provides non-medical services to its network of eyecare professionals, announced 2 new partnerships.

Ocuphire Pharma, FamyGen Life Sciences Sign $35 Million Global License Agreement for Nyxol Eye Drops

By Staff
Wednesday, November 9, 2022 12:15 AM FARMINGTON HILLS, Mich.—Ocuphire Pharma has concluded an exclusive license agreement with FamyGen Life Sciences (Famy) for the development and commercialization of Nyxol across three indications in the U.S., Europe, Japan, India, China and other global markets. In connection with its separately announced transaction with Famy, Viatris, a leading global health care company, has agreed to commercialize Nyxol following each regulatory approval. “Famy and Ocuphire have been engaging for several months, in a collaborative spirit, to conclude this agreement.